1 to 6 month formulation for the treatment of prostate cancer, of endometriosis, precocious puberty, uterine fibroids, ovarian cancer, breast cancer, female infertility.
Approximately 400 people of more than 18 nationalities from Europe, North and South America, Africa and Asia are employed at Debiopharm Group™ on its sites.
Debiopharm's vision of healthcare is not limited to making new medicines available. We strongly believe that you can be an actor in your own medical care. Your safety is our top priority.